文献速递乳腺癌放疗放疗物理与技术

槲皮素对人正常与癌细胞辐射适应性调控的差异

Differential regulation of radioadaptation by quercetin between human normal and cancer cells.
PubMed 文献 · Clin Transl Radiat Oncol · 2025-12-17

本研究在MCF10A正常乳腺上皮细胞与MCF7乳腺癌细胞中比较低剂量放疗(0.1 Gy)、槲皮素及高剂量辐射对细胞活力、克隆存活、氧化应激和DNA损伤反应的影响。结果显示槲皮素增强正常细胞的辐射适应性(涉及NQO1、NRF2与ROS),而在癌细胞中不诱导适应并可能提高放射敏感性。提示槲皮素或可作为放疗调节剂以扩大治疗窗。

要点

  • 槲皮素增强MCF10A正常细胞的辐射适应性并提高细胞活力与存活分数。
  • 机制涉及NQO1/NRF2抗氧化通路激活与24 h ROS降低。
  • MCF7癌细胞无辐射适应反应,槲皮素反而增加其放射敏感性。

核心结论

  • 槲皮素通过激活抗氧化通路并减少DNA损伤选择性增强正常细胞的辐射适应性,同时在癌细胞中保持或放大放射敏感性。
  • 作者认为槲皮素可能作为具有良好安全性的潜在放疗调节剂,用于增大放疗治疗窗。

研究设计与样本

  • 细胞实验比较人正常乳腺上皮MCF10A与乳腺癌MCF7细胞在低剂量放疗(0.1 Gy)、槲皮素及高剂量辐射处理后的反应。
  • 评估指标包括细胞活力、克隆存活、氧化应激与DNA损伤反应,并用RT-qPCR、Western blotting和免疫荧光检测NQO1与NRF2表达,以γ-H2AX焦点和p-ATM水平评价DNA损伤。

主要发现

  • 在MCF10A细胞中,低剂量放疗预处理增强其对后续辐射的抵抗,槲皮素进一步增强该效应:细胞活力升高(p = 0.007),10%存活分数下存活分数增强比=0.85。
  • MCF10A中槲皮素在4 h增强NQO1 mRNA(p < 0.01)与蛋白(p < 0.01)表达,24 h对NQO1 mRNA(p = 0.890)与蛋白(p = 0.453)影响有限,并降低24 h ROS水平(p = 0.021)。
  • 槲皮素促进MCF10A中NRF2去定位(p = 0.005)。
  • MCF7细胞未见辐射适应反应,槲皮素反而增加放射敏感性(10%存活分数下存活分数增强比=1.12),并维持ROS水平与DNA损伤。

临床怎么用

  • 结果提示槲皮素可能作为放疗调节剂,在保护正常组织的同时不削弱甚至增强对乳腺癌细胞的杀伤,但尚需进一步验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Radiotherapy is a primary treatment for many cancers, but its efficacy is often limited by collateral damage to healthy tissues. Radioadaptation, a phenomenon where low-dose radiotherapy (LDRT) enhances a cell's ability to withstand subsequent high-dose radiation, occurs in normal cells but is generally absent in cancer cells. Quercetin, a natural flavonoid with antioxidant and anticancer properties, has been proposed as a potential radiomodulator. This study aimed to investigate whether quercetin could differentially regulate the radioadaptive response in human normal breast epithelial versus breast cancer cells. METHODS: Cell viability, clonogenic survival, oxidative stress, and DNA damage responses were assessed in MCF10A and MCF7 cells following treatment with LDRT (0.1 Gy), quercetin, and high-dose radiation. NQO1 and NRF2 expression levels were measured using RT-qPCR, Western blotting, and immunofluorescence. DNA damage was evaluated by γ-H2AX foci and p-ATM levels. RESULTS: In MCF10A cells, LDRT pre-treatment enhanced resistance to subsequent radiation, which was further potentiated by quercetin, as shown by increased cell viability (p = 0.007), increased surviving fraction (enhancement ratio = 0.85, at 10 % surviving fraction), enhanced adaptation at 4 h on NQO1 mRNA (p < 0.01) and protein expression (p < 0.01), with a modest effect at 24 h on NQO1 mRNA (p = 0.890) and protein (p = 0.453) and reduced ROS level at 24 h (p = 0.021). Quercetin promoted NRF2 delocalization (p = 0.005). In contrast, MCF7 cells showed no radioadaptive response, and quercetin even increased radiosensitivity (enhancement ratio of surviving fraction = 1.12, at 10 surviving fraction) by maintaining ROS levels and DNA damage. CONCLUSION: Quercetin selectively enhances radioadaptation in normal cells by activating antioxidant pathways and reducing DNA damage, while preserving or amplifying radiosensitivity in cancer cells. These findings support quercetin may serve as a potential radiomodulating agent with favorable safety for increasing the therapeutic window of radiotherapy.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Li C, Li X, Biemans R, et al. Differential regulation of radioadaptation by quercetin between human normal and cancer cells. Clin Transl Radiat Oncol. 2025. PMID: 41531942. doi:10.1016/j.ctro.2025.101099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。